BALAXI PHARMACEUTICALS share news, announcements and annual reports

NSE: BALAXIPharmaceuticals & BiotechnologySmall Cap

BALAXI PHARMACEUTICALS LIMITED · Formerly Balaxi Ventures · Face value ₹2 · Listed Nov 2015

₹19.15₹0.56 (2.84%)

Share price at the NSE close on 30 Oct 2026. Previous close ₹19.71.

30 Oct: open ₹19.99, high ₹19.99, low ₹18.70

52-week range of traded prices to 30 Oct 2026

₹15.20Low, 27 Mar 2026₹43.85High, 4 Nov 2025

Next results date: the board meets on 12 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar

Market cap: ₹106 Cr2,722nd largest listed
P/E: 43.61
P/B: 0.42
Dividend yield: Nonein the last 12 months
ROE: 1.0%
ROCE: 2.1%
Debt to equity: 0.22
Volume, NSE: 21,37768.9% delivered

BALAXI PHARMACEUTICALS board meetings

97 filed, newest first. Page 2 of 2.

Apr 2021
- 9 Apr · Board meeting
  To consider Fund Raising
Jan 2021
- 19 Jan · Board meeting
  Board meeting held on January 19, 2021.
- 12 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
Oct 2020
- 12 Oct · Board meeting
  Board meeting held on October 12, 2020.
- 5 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020
Jul 2020
- 22 Jul · Board meeting
  Board meeting held on July 22, 2020.
- 14 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020
Jun 2020
- 16 Jun · Board meeting
  Board meeting held on Jun 16, 2020.
- 9 Jun · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020
Feb 2020
- 14 Feb · Board meeting
  Outcome of Board Meeting held on February 14, 2020.
- 5 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019
Oct 2019
- 29 Oct · Board meeting
  Board meeting held on October 29, 2019.
- 21 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019
Aug 2019
- 9 Aug · Board meeting
  Board meeting held on August 09, 2019.
- 1 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019
Jun 2019
- 20 Jun · Board meeting
  Board meeting held on Jun 19, 2019.
- 11 Jun · Board meeting
  To consider other business matters and the investment proposals for company's business expansion.
May 2019
- 3 May · Board meeting
  Board meeting held on May 03, 2019.
Apr 2019
- 25 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019
Feb 2019
- 1 Feb · Board meeting
  Board meeting held on February 01, 2019.
Jan 2019
- 21 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2018 and other business matters
Nov 2018
- 10 Nov · Board meeting
  Outcome of Board Meeting held on November 09, 2018.
Oct 2018
- 31 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018
Aug 2018
- 20 Aug · Board meeting
  Board meeting held on August 20, 2018.
- 6 Aug · Board meeting
  Board meeting held on August 06, 2018.
Jul 2018
- 28 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018
May 2018
- 5 May · Board meeting
  Board meeting held on May 05, 2018.
Apr 2018
- 27 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018 and other business matters
Feb 2018
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2018.
- 6 Feb · Board meeting
  Inter alia to consider and approve the following matter; I) Unaudited Financial Results of the company for the Quarter and Nine Months ended on December 31, 2017. ii) To consider and approve the raising of funds through Preferential issue of Securities in terms of the Chapter VII of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, Section 42 and 62(1) of the Companies Act, 2013 read with relevant rules made thereunder and other applicable laws, if any to the persons belonging to Promoter(s)/ Non-Promoter(s) category.
Nov 2017
- 10 Nov · Board meeting
  Outcome of Board Meeting held on November 10, 2017.
- 3 Nov · Board meeting
  Inter alia to consider and approve the Un-Audited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2017.
Aug 2017
- 30 Aug · Board meeting
  Outcome of Board Meeting held on August 30, 2017.Pursuant to Regulation 30 read with part A of Schedule III of SEBI( Listing Obligation and Disclosure Requirement) Regulations 2015, We wish to inform you that the Directors of the Company at their Board Meeting held today ie 30.08.2017 approved inter alia the following;1. Decided to issue 2,20,00,000 ( Two Crores Twenty Lakhs) Equity share of the company of the Face value of Rs. 10/-(Rupees Ten) each at a price of Rs. 15/- (Rupees Fifteen)(including a premium of Rs. 5/-(Rupees Five) per share, to the prospective investors of the Company including promoter group by way of Preferential Issue, subject to approval of shareholders of the Company in forthcoming Annual General Meeting(AGM) and the Board designate a committee as Capital Infusion Committee to find and finalize the list of prospective investors. Further we hereby inform you that, we will intimate your good office before sending the Notice to shareholders, the list of prospective investors including promoter group along with Number of shares offered, once the designated committee decide and approve the same.2. The 74th Annual General Meeting of the company will be held on Saturday, September 30, 2017 at 11.30 A.M at Registered Office of the company.3. In terms of Regulation 44 of SEBI(Listing Obligation and Disclosure Requirements ) Regulation 2015 and Section 108 of Companies Act 2013 read with relevant Rules, the company is offering E-voting facility to its members in respect of the business to be transacted at the 74th Annual General Meeting.The e-voting period commences at 9:00 a.m. on September 27, 2017 and ends at 5:00 p.m. on September 29, 2017. The cutoff date for the purpose of E-voting is September 23, 20174. The Register of Members and Share Transfer Books of the Company will remain closed from September 24, 2017 to September 30, 2017 (both days inclusive) for the purpose of 74th Annual General Meeting.5. Board Decided to appoint of M/s. S R B C & CO LLP, Chartered Accountants (FRN: 324982E/E300003), as new statutory auditors of Company to hold office for one term of 5 years commencing from conclusion of ensuing 74th Annual General Meeting upto Annual General Meeting of the Company to be held in calendar year 2022 subject to the approval of Shareholders in the forthcoming Annual General Meeting.
- 22 Aug · Board meeting
  Inter alia to consider the following agenda items along with other items; 1. To discuss and consider the proposal for issue of Equity Shares, by way of Preferential Issue, subject to approval of shareholders of the Company under section 62(1)(c) of the Companies Act, 2013 and other applicable laws. 2. To decide the date, time and venue of Annual General Meeting; 3. To decide the Book Closure dates; 4. To appoint Statutory Auditor for the Company.
Jul 2017
- 29 Jul · Board meeting
  Inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter and Three Months ended on June 30, 2017.
- 6 Jul · Board meeting
  Outcome of Board Meeting held on July 06, 2017.
Jun 2017
- 28 Jun · Board meeting
  To Transact/Consider, inter alia the following business. 1. To take note that, Balaxi Overseas Private Limited have become the Promoters of the company. 2. To Change the name of the company to Balaxi Ventures Limited . 3. To consider the proposal for shifting of Registered Office of the company. 4. To amend/alter the Memorandum & Articles of Association. 5. To consider the proposal for increasing the Authorized Capital of the Company. 6. To seek approval of the shareholders for all or any of the above matters and also other matters as may be deemed appropriate.
May 2017
- 5 May · Board meeting
  Outcome of Board Meeting held on May 04, 2017.
- 5 May · Board meeting
  Outcome of Board Meeting held on May 04, 2017.
Apr 2017
- 17 Apr · Board meeting
  Inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on March 31, 2017.
Jan 2017
- 19 Jan · Board meeting
  Inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and Nine Months ended on December 31, 2016.
Nov 2016
- 30 Nov · Board meeting
  Outcome of meeting of the Board of Directors of the Company held on November 30, 2016.
Oct 2016
- 28 Oct · Board meeting
  Inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and Half Year ended on September 30, 2016.
Aug 2016
- 25 Aug · Board meeting
  Outcome of board meeting held on August 25, 2016.
Jul 2016
- 20 Jul · Board meeting
  Inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and three months ended on June 30, 2016.
May 2016
- 17 May · Board meeting
  Inter alia to consider and approve the Audited Financial Results of the company for the Quarter and Year ended on March 31, 2016.
Jan 2016
- 23 Jan · Board meeting
  Inter alia to consider and approve the unaudited Financial Results of the company for the quarter and nine months ended on December 31, 2015.

BALAXI PHARMACEUTICALS board meetings

Apr 2021

Jan 2021

Oct 2020

Jul 2020

Jun 2020

Feb 2020

Oct 2019

Aug 2019

Jun 2019

May 2019

Apr 2019

Feb 2019

Jan 2019

Nov 2018

Oct 2018

Aug 2018

Jul 2018

May 2018

Apr 2018

Feb 2018

Nov 2017

Aug 2017

Jul 2017

Jun 2017

May 2017

Apr 2017

Jan 2017

Nov 2016

Oct 2016

Aug 2016

Jul 2016

May 2016

Jan 2016